Matches in Wikidata for { <http://www.wikidata.org/entity/Q94408337> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- Q94408337 description "article scientifique publié en 2017" @default.
- Q94408337 description "wetenschappelijk artikel" @default.
- Q94408337 description "наукова стаття" @default.
- Q94408337 name "QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL" @default.
- Q94408337 name "QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL" @default.
- Q94408337 type Item @default.
- Q94408337 label "QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL" @default.
- Q94408337 label "QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL" @default.
- Q94408337 prefLabel "QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL" @default.
- Q94408337 prefLabel "QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL" @default.
- Q94408337 P1433 Q94408337-371600C7-EA4B-4978-A627-6EF1145F4EC8 @default.
- Q94408337 P1476 Q94408337-88C92BF2-84F5-4187-BF1C-B68989B25569 @default.
- Q94408337 P2093 Q94408337-06D717A5-97DB-42D0-9975-F74CD4FBE7E6 @default.
- Q94408337 P2093 Q94408337-17F51C91-FE4E-4BD9-95D4-0828F34ABE67 @default.
- Q94408337 P2093 Q94408337-20EEF7C8-7204-4995-A136-964C99697DAF @default.
- Q94408337 P2093 Q94408337-39461FC2-977F-411A-A8F9-A40B413ECFDA @default.
- Q94408337 P2093 Q94408337-434DD92D-85ED-44CC-9800-8C1D94A427C1 @default.
- Q94408337 P2093 Q94408337-466703B6-1D0F-4A78-9AD9-012438350D3B @default.
- Q94408337 P2093 Q94408337-50E7AB1B-9A52-42EC-98D2-D8405B33E44D @default.
- Q94408337 P2093 Q94408337-585E7B64-B31C-4988-9E82-C2FDBF17A91A @default.
- Q94408337 P2093 Q94408337-76A7FFE1-FD45-4A44-B8D2-FCF789E57603 @default.
- Q94408337 P2093 Q94408337-7709CD16-61F8-4241-B2EE-778D10B81ABE @default.
- Q94408337 P2093 Q94408337-99EEEEB7-58DE-4073-864C-323405C918FE @default.
- Q94408337 P2093 Q94408337-9F9BF3A9-61DF-4261-A91D-07EDE6EA4022 @default.
- Q94408337 P2093 Q94408337-C28AEC03-93F9-4FCE-8705-F3543499212D @default.
- Q94408337 P2093 Q94408337-D2280B6B-0E87-4E7F-A9DF-48944CCB7BA6 @default.
- Q94408337 P2093 Q94408337-DDDBEBB6-275A-433E-8464-3EFBD147F9D9 @default.
- Q94408337 P2093 Q94408337-EA106680-C3A8-4115-AB87-9BEFF3FFBC3E @default.
- Q94408337 P2093 Q94408337-F7371BDC-3F82-41D7-B43E-10BA1C722594 @default.
- Q94408337 P2093 Q94408337-FE942F57-3DD1-4D4D-AEB5-386FC1E2548D @default.
- Q94408337 P304 Q94408337-64045829-A7F5-4AC7-8206-CDCAD8EB4C61 @default.
- Q94408337 P31 Q94408337-B0A17605-4FD1-4411-9AEB-B190AA651CA0 @default.
- Q94408337 P356 Q94408337-0FC9AB8A-9EEB-49DD-96C3-742EE8306C81 @default.
- Q94408337 P433 Q94408337-23892B00-9890-4A53-9CD1-70F7F77B0D6A @default.
- Q94408337 P478 Q94408337-F133BD87-56CB-4F27-8426-5098FC0B43C0 @default.
- Q94408337 P50 Q94408337-7557DCCD-747D-480E-8A64-0E7277B9130E @default.
- Q94408337 P577 Q94408337-7C92CF42-B5A6-4594-BFCB-E5E3F1EE3B8C @default.
- Q94408337 P921 Q94408337-4B5AAE3A-225F-4797-8DB8-FC9FFFC98C22 @default.
- Q94408337 P932 Q94408337-1D4EF95F-A0A2-4E99-8E80-7A9520FD8B06 @default.
- Q94408337 P356 NOX168.834 @default.
- Q94408337 P1433 Q15724471 @default.
- Q94408337 P1476 "QLIF-25. EFFECT OF TUMOR TREATING FIELDS (TTFIELDS) ON HEALTH-RELATED QUALITY OF LIFE (HRQoL) IN NEWLY DIAGNOSED GLIOBLASTOMA. RESULTS OF THE EF-14 RANDOMIZED PHASE III TRIAL" @default.
- Q94408337 P2093 "Alessandro Olivi" @default.
- Q94408337 P2093 "Carlos A David" @default.
- Q94408337 P2093 "Chae-Yong Kim" @default.
- Q94408337 P2093 "Eilon D Kirson" @default.
- Q94408337 P2093 "Garth A Nicholas" @default.
- Q94408337 P2093 "Gitit Lavy-Shahaf" @default.
- Q94408337 P2093 "Jacob C Easaw" @default.
- Q94408337 P2093 "Jan Sroubek" @default.
- Q94408337 P2093 "Jerôme Honnorat" @default.
- Q94408337 P2093 "Jordi Bruna Escuder" @default.
- Q94408337 P2093 "Linda Dirven" @default.
- Q94408337 P2093 "Martin J B Taphoorn" @default.
- Q94408337 P2093 "Rajiv D Desai" @default.
- Q94408337 P2093 "Roger Stupp" @default.
- Q94408337 P2093 "Sophie Taillibert" @default.
- Q94408337 P2093 "Thomas Chen" @default.
- Q94408337 P2093 "Yvonne Kew" @default.
- Q94408337 P2093 "Zvi Ram" @default.
- Q94408337 P304 "vi206-vi206" @default.
- Q94408337 P31 Q13442814 @default.
- Q94408337 P356 "10.1093/NEUONC/NOX168.834" @default.
- Q94408337 P433 "Suppl 6" @default.
- Q94408337 P478 "19" @default.
- Q94408337 P50 Q85360289 @default.
- Q94408337 P577 "2017-11-06T00:00:00Z" @default.
- Q94408337 P921 Q42824827 @default.
- Q94408337 P932 "5692873" @default.